What is the appropriate treatment for orthostatic hypotension?

Treatment of Orthostatic Hypotension

Start with nonpharmacological interventions first—including medication review, increased salt and fluid intake (8-10g sodium daily), compression garments (at least thigh-high, preferably abdominal), and physical counter-pressure maneuvers—before advancing to pharmacological therapy with midodrine or droxidopa for persistent symptoms. 1

Stepwise Treatment Algorithm

Step 1: Medication Review and Optimization

• Immediately review and discontinue or reduce causative medications including diuretics, vasodilators, antihypertensives, antidepressants, and antiparkinsonian drugs 1, 2
• This is the most critical first step, as medication-induced OH is frequently overlooked, especially in polypharmacy situations 3

Step 2: Nonpharmacological Interventions (First-Line)

These serve as the foundation and may suffice for milder cases 4:

Dietary modifications:

• Increase salt intake to 8-10g daily (unless contraindicated by heart failure)
• Increase fluid intake to 2-2.5 liters daily
• Acute water ingestion (≥480 mL) provides temporary relief within 30 minutes 1
• Avoid glucose or salt in water as these reduce the pressor effect 1

Compression therapy:

• Use at least thigh-high compression garments, preferably including the abdomen
• Shorter garments have not proven beneficial 1
• These improve orthostatic symptoms and blunt blood pressure decreases 1

Physical counter-pressure maneuvers:

• Leg crossing, lower body muscle tensing, squatting, and maximal handgrip
• Squatting produces the largest blood pressure increase
• Requires adequate prodrome warning and physical ability to perform safely 1

Behavioral modifications:

• Avoid prolonged standing, hot environments, and large meals
• Sleep with head of bed elevated 10-20 degrees to reduce nocturnal diuresis 4
• Rise slowly from supine to sitting to standing positions

Step 3: Pharmacological Treatment (When Nonpharmacological Measures Insufficient)

For neurogenic orthostatic hypotension specifically:

First-line medications:

• Midodrine (FDA-approved): Dose-dependent effect, usually improves standing blood pressure and symptoms 1

  • Common side effects: supine hypertension (limiting factor), scalp tingling, piloerection, urinary retention 1

• Droxidopa (FDA-approved): Effective for neurogenic OH due to Parkinson disease, pure autonomic failure, and multiple system atrophy 1

  • May reduce falls in small studies
  • Carbidopa in Parkinson patients may decrease droxidopa effectiveness
  • Side effects: supine hypertension, headache, dizziness, nausea 1

Second-line medication:

• Fludrocortisone: Increases plasma volume, improving OH symptoms 1
  • Use only when supine hypertension is absent—other medications should be tried first if supine hypertension present 1
  • Side effects: edema, hypokalemia, headache
  • Serious adverse reactions (adrenal suppression, immunosuppression) with doses >0.3 mg daily 1
  • Concerning long-term effects limit its use 2

Step 4: Treatment Combinations for Refractory Cases

When single agents fail, combine therapies from different categories 4

Critical Caveats and Pitfalls

Supine hypertension coexistence:

• Frequently coexists with OH, especially in neurogenic cases 5, 6
• Screen all OH patients for supine hypertension to inform treatment approach 5
• Limits use of fludrocortisone and may complicate midodrine/droxidopa dosing 1

Postprandial hypotension:

• Screen all OH patients for this condition 5
• Modify meal size and composition; avoid large carbohydrate-rich meals

Treatment targets:

• Focus on symptom relief and fall prevention, not blood pressure numbers 5
• Asymptomatic OH still increases mortality risk and warrants treatment 5, 6

Special populations:

• Adolescents (12-19 years): Use nonpharmacological treatments primarily; midodrine has shown benefit in small pediatric trials if needed 7
• Older adults with frailty (>70 years): Require screening even if asymptomatic 5

Avoid harmful interventions:

• Do NOT use radiofrequency sinus node ablation, jugular venoplasty, or Chiari decompression for OH—these lack efficacy and may cause harm 7, 1

Evidence Quality Note

The 2017 ACC/AHA/HRS guideline 1 provides the strongest framework for OH treatment, with clear recommendations for both nonpharmacological and pharmacological approaches. The evidence base relies heavily on small observational studies and case series rather than large randomized trials 1, but the guideline recommendations represent expert consensus synthesizing available data. Recent reviews 5, 6, 2 reinforce this stepwise approach prioritizing nonpharmacological interventions before medications.